Researchers from Stanford University and the Palo Alto Veterans Administration Health Care System Successfully Complete Initial Pilot Study Focused on Illustrating the Physiologic Effects of the Cyclic Variations in Altitude Conditioning™ Process
CVAC Systems, Inc. has been informed by researchers from Stanford University and the Palo Alto Veterans Administration Health Care System (VAPAHCS) that the initial pilot study of the physiologic effects of the Cyclic Variations in Altitude Conditioning (CVAC™) process has been successfully completed. As a result of these pilot data, larger, more extensive studies are planned.
Temecula, CA (PRWEB) February 6, 2007
CVAC Systems, Inc. has been informed by researchers from Stanford University and the Palo Alto Veterans Administration Health Care System (VAPAHCS) that the initial pilot study of the physiologic effects of the Cyclic Variations in Altitude Conditioning (CVAC™) process has been successfully completed. As a result of these pilot data, larger, more extensive studies are planned.
The principal investigator of the study is Anne L. Friedlander, Ph. D., Director of the Exercise Physiology Lab in the Clinical Studies Unit and a Consulting Professor for the Program in Human Biology at Stanford University. Dr. Friedlander reported that all four athletes studied were able to complete the 6-8-week protocol and testing with full compliance and no significant adverse effects. "These data provide us with the necessary logistical information and observations to allow us to move forward with a much larger sample size," explained Dr. Friedlander.
While the data remain confidential pending the larger study and publication, Dr. Friedlander did report that the preliminary results appear promising and suggest a strong impact of the CVAC exposures on the altitude acclimatization process. "We are eager to move forward with the larger study which we expect will expand on our preliminary findings and begin to identify the underlying mechanisms of change caused by the CVAC sessions," commented Dr. Friedlander.
"We are very pleased with the quality of the research and results Dr. Friedlander and her staff of researchers at Stanford University and the VAPAHCS are providing to this fundamental research into the remarkable physiological effects of CVAC. We look forward to a long and fruitful relationship as we mutually explore the many potential applications of CVAC technology which include insulin resistance, metabolic syndrome and diabetes in addition to exercise performance enhancement," commented Allen J. Ruszkowski, President and CEO of CVAC Systems, Inc.
About VAPAHCS
VAPAHCS is a teaching hospital, providing a full range of patient care services, with state-of-the-art technology as well as education and research. VAPAHCS maintains one of the top three research programs in the VA. An affiliation with the Stanford University School of Medicine provides a rich academic environment including medical training for physicians in virtually all specialties and subspecialties.
About CVAC Systems, Inc.
CVAC Systems, Inc., headquartered in Temecula, Calif., is privately funded and is seeking to place CVAC systems at key luminary research sites for the development of several patent-pending applications such as performance enhancement, disease prevention, therapy and advanced health. For these plans, the Company is seeking a first-round venture/institutional financing.
Please note: The information contained within this document is intended for prospective researchers only, and is not intended for patients or health care providers. Any references to therapeutic applications are for discussion and research purposes only.
Copyright © 2007, CVAC Systems, Inc. All rights reserved. Cyclic Variations in Altitude Conditioning, CVAC and CVAC logo are trademarks or registered trademarks of CVAC Systems, Inc. in the United States and/or other Countries. All other trademarks belong to their respective owners. No affiliation is expressed or implied herein.
###
